磷酸化血小板源性生長(zhǎng)因子受體-α抗體品牌 英文名稱  Anti-Phospho-PDGFRA(Tyr754)

中文名稱  磷酸化血小板源性生長(zhǎng)因子受體-α抗體品牌 

別    名 PDGF Receptor alpha; Platelet–dirived growth factor receptor-alpha; Alpha platelet derived growth factor receptor; CD 140a; CD140a; CD140a antigen; MGC74795; PDGF alpha chain; PDGF R alpha; PDGFR 2; PDGFR A; PDGFR alpha; PDGFR2; PDGFRA; Platelet derived growth factor receptor 2; Platelet derived growth factor receptor alpha; Platelet derived growth factor receptor alpha polypeptide; PGFRA_HUMAN.

產(chǎn)品屬性：

濃    度  1mg/1ml

規(guī) 格  0.1ml/100μg

抗體來源  Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Dog, Cow, Horse, Sheep

產(chǎn)品類型   一抗 磷酸化抗體  

研究領(lǐng)域     免疫學(xué) 細(xì)胞凋亡 轉(zhuǎn)錄調(diào)節(jié)因子 激酶和磷酸酶 細(xì)胞膜受體

蛋白分子量  predicted molecular weight: 117kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated Synthesised phosphopeptide derived from human PDGF Receptor alpha around the phosphorylation site of Tyr754 [SK(p-Y)SD]

亞    型  IgG

純化方法   affinity purified by Protein A

儲(chǔ) 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

磷酸化血小板源性生長(zhǎng)因子受體-α抗體品牌 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 The PDGF Receptor Type A (Alpha platelet-derived growth factor receptor precursor, CD140a antigen), a 170kD protein, binds all three isoforms of PDGF with high affinity whereas the PDGF Receptor Type B, a 190kD protein, appears to bind only the PDGF BB homodimer with high affinity. Both receptors are transmembranous, ligand activated protein tyrosine kinases, which phosphorylate a number of important signal transduction proteins, which are bound with differential affinities via SH2 domains. The response of any given cell to PDGF will depend on the types of receptors displayed on the surface and isoforms of PDGF present in the extracellular environment.

Function : Tyrosine-protein kinase that acts as a cell-surface receptor for PDGFA, PDGFB and PDGFC and plays an essential role in the regulation of embryonic development, cell proliferation, survival and chemotaxis. Depending on the context, promotes or inhibits cell proliferation and cell migration. Plays an important role in the differentiation of bone marrow-derived mesenchymal stem cells. Required for normal skeleton development and cephalic closure during embryonic development. Required for normal development of the mucosa lining the gastrointestinal tract, and for recruitment of mesenchymal cells and normal development of intestinal villi. Plays a role in cell migration and chemotaxis in wound healing. Plays a role in platelet activation, secretion of agonists from platelet granules, and in thrombin-induced platelet aggregation. Binding of its cognate ligands - homodimeric PDGFA, homodimeric PDGFB, heterodimers formed by PDGFA and PDGFB or homodimeric PDGFC -leads to the activation of several signaling cascades; the response depends on the nature of the bound ligand and is modulated by the formation of heterodimers between PDGFRA and PDGFRB. Phosphorylates PIK3R1, PLCG1, and PTPN11. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate, mobilization of cytosolic Ca(2+) and the activation of protein kinase C. Phosphorylates PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and thereby mediates activation of the AKT1 signaling pathway. Mediates activation of HRAS and of the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3 and STAT5A and/or STAT5B. Receptor signaling is down-regulated by protein phosphatases that dephosphorylate the receptor and its down-stream effectors, and by rapid internalization of the activated receptor.

Subunit : Interacts with homodimeric PDGFA, PDGFB and PDGFC, and with heterodimers formed by PDGFA and PDGFB. Monomer in the absence of bound ligand. Interaction with dimeric PDGFA, PDGFB and/or PDGFC leads to receptor dimerization, where both PDGFRA homodimers and heterodimers with PDGFRB are observed. Interacts (tyrosine phosphorylated) with SHB (via SH2 domain). Interacts (tyrosine phosphorylated) with SHF (via SH2 domain). Interacts (tyrosine phosphorylated) with SRC (via SH2 domain). Interacts (tyrosine phosphorylated) with PIK3R1. Interacts (tyrosine phosphorylated) with PLCG1 (via SH2 domain). Interacts (tyrosine phosphorylated) with CRK, GRB2 and GRB7. Interacts with human cytomegalovirus/HHV-5 envelop glycoprotein B/gB.

Subcellular Location : Cell membrane; Single-pass type I membrane protein. Note=The activated receptor is rapidly internalized and degraded.

Post-translational modifications : N-glycosylated.

Ubiquitinated, leading to its degradation (Probable).

Autophosphorylated on tyrosine residues upon ligand binding. Autophosphorylation occurs in trans, i.e. one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit. Phosphorylation at Tyr-731 and Tyr-742 is important for interaction with PIK3R1. Phosphorylation at Tyr-720 and Tyr-754 is important for interaction with PTPN11. Phosphorylation at Tyr-762 is important for interaction with CRK. Phosphorylation at Tyr-572 and Tyr-574 is important for interaction with SRC and SRC family members. Phosphorylation at Tyr-988 and Tyr-1018 is important for interaction with PLCG1.

DISEASE : Note=A chromosomal aberration involving PDGFRA is found in some cases of hypereosinophilic syndrome. Interstitial chromosomal deletion del(4)(q12q12) causes the fusion of FIP1L1 and PDGFRA (FIP1L1-PDGFRA). Mutations that cause overexpression and/or constitutive activation of PDGFRA may be a cause of hypereosinophilic syndrome.

Defects in PDGFRA are a cause of gastrointestinal stromal tumor (GIST) [MIM:606764]. Note=Mutations that cause constitutive activation of PDGFRA may be a cause of gastrointestinal stromal tumor (GIST).

Similarity : Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.

Contains 5 Ig-like C2-type (immunoglobulin-like) domains.

Contains 1 protein kinase domain.

Database links : UniProtKB/Swiss-Prot: P16234.1

細(xì)胞膜受體（Membrane Receptors)

PDGFR-α是膜受體，具有酪氨酸酶的活性，與其配體PDGF結(jié)合后激活與細(xì)胞增殖有關(guān)的酶及基因。 PDGFR亦表達(dá)于上皮、內(nèi)皮細(xì)胞，、皮膚、腎小球等上皮細(xì)胞均有PDGFR表達(dá). 亦有學(xué)者報(bào)道血小板源性生長(zhǎng)因子受體α抗體在細(xì)胞胞漿胞膜、胞核都有不同的表達(dá)還有人認(rèn)為：PDGF及其受體一般表達(dá)于浸潤(rùn)組織的細(xì)胞附近，組織缺血損傷、腎小球高壓、免疫因素作用、細(xì)胞浸潤(rùn)、實(shí)質(zhì)細(xì)胞活化等導(dǎo)致PDGFR表達(dá)增強(qiáng)。

實(shí)驗(yàn)流程：

全、新、優(yōu)、品、好四大特點(diǎn)：

磷酸化血小板源性生長(zhǎng)因子受體-α抗體品牌 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。

新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。

好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。

正在熱銷的相關(guān)產(chǎn)品：

Anti-DEC-205/CD205/Ly75/FITC 熒光素標(biāo)記CD205抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Anti-MAP-2/FITC 熒光素標(biāo)記微管相關(guān)蛋白2抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh Calmodulin/CaM I 鈣調(diào)節(jié)素抗體(鈣調(diào)蛋白/鈣調(diào)素) 規(guī)格 0.1ml

Anti-CSP (circumsporozoite protein/Plasmodium yoelii) 環(huán)子孢子蛋白(約氏)抗原 0.5mg

HSD3B7 英文名稱： 滋養(yǎng)層細(xì)胞抗原3β7抗體 0.2ml

Rhesus antibody Rh SERPINB10 絲氨酸蛋白酶抑制劑B10抗體 規(guī)格 0.2ml

Anti-MAP-2/FITC 熒光素標(biāo)記微管相關(guān)蛋白2抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Anti-Lysozyme/FITC 熒光素標(biāo)記溶菌酶抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Anti-phospho-Tau protein (Ser396)/FITC 熒光素標(biāo)記磷酸化微管相關(guān)蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh ADCK4 ADCK4蛋白抗體 規(guī)格 0.2ml

Rabbit Anti-dog IgG/Gold 膠體金標(biāo)記的兔抗狗IgG 0.5ml

Cancer/testis antigen family 4 member 7 英文名稱： /抗原家族4亞型7抗體 0.2ml

Rhesus antibody Rh Rabbit Anti-chicken IgG/FITC FITC標(biāo)記的兔抗雞IgG 規(guī)格 0.3ml

Anti-phospho-Tau protein (Ser396)/FITC 熒光素標(biāo)記磷酸化微管相關(guān)蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml

COLEC11(Human collectin sub-family member 11) ELISA Kit 人集蛋白亞家族成員11Multi-class antibodies規(guī)格： 48T

Anti-PAP2c 磷脂酸磷酸酶2C抗體Multi-class antibodies規(guī)格： 0.1ml

Rhesus antibody Rh HOXB8 同源盒蛋白B8抗體 規(guī)格 0.2ml

CH50(Mouse 50% complement hemolysis)ELISA Kit 小鼠血清總補(bǔ)體 96T

Phospho-PERK(Thr980) 英文名稱： 磷酸化蛋白激酶樣內(nèi)質(zhì)網(wǎng)激酶抗體 0.1ml

Alpha casein 英文名稱： α酪蛋白抗體 0.2ml

Anti-PAP2c 磷脂酸磷酸酶2C抗體Multi-class antibodies規(guī)格： 0.1ml

CL-0313293FT(人胚腎細(xì)胞)5×106cells/瓶×2

SPINK4 Others Mouse 小鼠 SPINK4 人細(xì)胞裂解液 (陽性對(duì)照)

小鼠氣管和上皮細(xì)胞完全培養(yǎng)基 100mL

C2C12小鼠成肌細(xì)胞 C2C12 mouse myoblasts DMEM+10%FBS

IL36A Protein Mouse 重組小鼠 IL-1F6 / IL-1 epsilon 蛋白

NCI-H838(人非小細(xì)胞細(xì)胞) 5×106cells/瓶×2 A9(皮下結(jié)締組織細(xì)胞)

CL-0309TG-905(人腦膠質(zhì)母細(xì)胞瘤細(xì)胞)5×106cells/瓶×2

HA Others H7N7 甲型 H7N7 (A/Netherlands/219/03) 血凝素 (Hemagglutinin / HA) 桿狀病毒-昆蟲細(xì)胞裂解液 (陽性對(duì)照)

人神經(jīng)元總RNAHN NA

SHG44細(xì)胞，細(xì)胞 人SV-40轉(zhuǎn)化,WI-38AV13細(xì)胞 膀胱成纖維細(xì)胞Many types of cells包裝：5 × 105次方(1ml)

豹貓皮膚成纖維樣細(xì)胞;LCS5

FLT4 Others Human 人 VEGFR3 / FLT4 人細(xì)胞裂解液 (陽性對(duì)照)

磷酸化血小板源性生長(zhǎng)因子受體-α抗體品牌 CD68 Others Rat 大鼠 CD68 / Macrosialin 人細(xì)胞裂解液 (陽性對(duì)照)

人小膠質(zhì)細(xì)胞總RNAHM NA

人真皮淋巴上皮細(xì)胞完全培養(yǎng)基 100mL

COS-7細(xì)胞，SV40轉(zhuǎn)化的非洲綠猴腎細(xì)胞 293T/17 [HEK 293T/17] (人胚腎細(xì)胞) 雜交瘤(B類);Z1510C6D10F4G6

EFNB2A Protein Danio rerio (zebrafish) 重組斑馬魚 EFNB2A / Ephrin B2a 蛋白 (His 標(biāo)簽)

Vero(非洲綠猴腎細(xì)胞) 5×106cells/瓶×2 小鼠胚胎成纖維細(xì)胞;3T3-L1

技術(shù)外包服務(wù):

★磷酸化血小板源性生長(zhǎng)因子受體-α抗體品牌 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等

★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。